The PennZone

  • Home
  • Entertainment
  • Marketing
  • Non-profit
  • Music
  • Books
  • Education
  • Business
  • Legal

AscellaHealth Named National Association of Specialty Pharmacy (NASP) Strategic Channel Partner of the Year
The PennZone/10201259

Trending...
  • Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
  • Sea Tales Strengthens U.S. Leadership Team as Retail Expansion Accelerates
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy solutions company, is extremely honored to be named Strategic Channel Partner of the Year at the recent National Association of Specialty Pharmacy (NASP) Annual Meeting & Expo. This award is given to an organization such as a manufacturer, technology provider, GPO, Hub service provider, logistics provider, nonprofit or other that provides a service or solution to facilitate the delivery of high-quality, cost-effective specialty pharmacy care.

Honored to receive this award, Dea Belazi, president and CEO, AscellaHealth says, "This extraordinary recognition by such an esteemed organization as NASP belongs to our talented team of strategic innovators with unparalleled industry experience and expertise. It is extremely gratifying to gain this unique distinction in the specialty pharmacy market and our entire organization is deserving of this honor."

AscellaHealth is part of The AscellaHealth Family of Companies: including subsidiaries Optime Care dedicated to rare, orphan/ultra-orphan disease patients and Terebellum, a global organization serving pharmaceutical manufacturers.

More on The PennZone
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
  • OneVizion Launches Vera AI, Bringing Connected Operational Context to Infrastructure Teams
  • P-Wave Press Announces Pushing the Wave 2025 by L.A. Davenport
  • DONGSHENG Titanium Recycling: Promoting a Closed-Loop Cycle for High-End Titanium Materials

Belazi continues, "The AscellaHealth Family of Companies provide single-source, end-to-end solutions to tighten the specialty pharmacy value chain. In the highly fragmented current marketplace with multiple vendors handling each stage of the pre-launch, commercialization, distribution and fulfilment processes, manufacturers value our one stop, consultative approach. Most importantly, we are always mindful of putting patients at the center of all our initiatives."

With a focus on optimizing access to expensive specialty and rare disease medications and improving patient outcomes, AscellaHealth provides a full spectrum of cutting-edge programs and services that are valued by all stakeholders, including patients, payers, life sciences manufacturers and providers. AscellaHealth core services include pre-commercialization and market access, comprehensive Hub and patient support, exclusive distribution partnerships and national specialty medication fulfillment, data analytics, supply chain logistics and payer/pharmaceutical financial solutions.

To learn more about AscellaHealth's unique life sciences solutions, email businessdevelopment@ascellahealth.com

About AscellaHealth LLC

AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, payers, life sciences manufacturers and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and personalized medical management services. A multiple Inc. 5000 winner, AscellaHealth's unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Most recently, AscellaHealth has joined with its subsidiaries, Optime Care and Terebellum to form the AscellaHealth Family of Companies. Visit www.AscellaHealth.com.

More on The PennZone
  • French Camp Academy Releases New Video Inviting Individuals to Consider a Life of Service
  • LET US READ Documentary on Dyslexia and Literacy to Screen at TCL Chinese 6 in Hollywood
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice

Contacts

Media:

Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Little Yellow Bungalow is an independent fashion and lifestyle brand founded by Denise Laudadio
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A!
  • Dividend Stacker Launches Free Calendar and Alerts for High-Yield ETF Payouts
  • Paul Ohana - From Beverly Hills Salon Chair To Beauty Founder Celebrity Hair Expert
  • ChargeOn Announces Conversational Payment Management Solution
  • King Larry Steps Into His Moment With Music, Major Performances and a Story Built on Persistence
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center
  • SHI Introduces the RP-222B3S, Its Highest-Capacity 4K Pulse Tube Cryocooler
  • Redefining Proactive Care: The Rise of the Hybrid Concierge Medical Model
  • As Canada and America Turn on Each Other, These Two Authors Stay On Speaking Terms
  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration
  • BrĂ©vant Guide Launches New National Restaurant Guide Across Canada
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not
  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing
  • VC Fast Pitch and Steamwork Ventures Bring Startup & Investor Networking Event to Santa Barbara on October 8
  • Volant Announces Major Partnership with the STEM Racing Canada Program to CHAMPION YOUTH ENGINEERING
  • Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States
  • 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
  • MommyAndMe.club Expands Parent-Child Class Directory to All 50 States and Washington, D.C

Popular on PennZone

  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing - 210
  • Easwe Lightweight Electric Wheelchair Collection with Travel-Focused Mobility Solutions - 186
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 177
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man - 174
  • 3ptechies Partners with Coolmuster to Give Away Data Recovery Software Licenses - 158
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event - 147
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers - 138
  • INAD Warriors' 4th Annual "Dancing with the INAD Stars" Gala - 128
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration - 124
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd - 117

Similar on PennZone

  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
  • Regcrest LLC Publishes Free 50-State Tax Account Closure Checklist Tool
  • HydroExcavation.com Relaunches With Exclusive Local Service Areas and Dedicated Hydrovac Manufacturer Directory
  • Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
  • Defense & Space Strategy Strengthens as New Leadership Builds on NASA Results and Expanding Multi-Orbit Opportunities for Ascent Solar Technologies
  • STS Capital Partners is pleased to announce the appointment of Barry Brown as Vice President, Business Development
  • Qscription Technologies and NEOPATHOLOGY CORP. Sign MOU to Bring FDA-Cleared Lung Imaging AI into U.S. Clinical Practice
  • Mandeville Pests May Pose Serious Health Risks for Your Family
  • ChargeOn Announces Conversational Payment Management Solution
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us